Referenser för eye q Författare, artikel och publikation |
År |
Hämta abstract / fulltext |
1. Haag M. Essential fatty acids and the brain.
Can J Psychiatry 48: 195-203; 2002. |
2002 |
|
2. Peet M, Brind J, Ramchand CN et al.
Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophenia.
Schizophrenia Research 49(3):243-51 |
|
|
3. Peet M, Horrobin DF.
A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.
Arch Gen Psychiatry 59(10):913-9; 2002 |
2002 |
|
4. Richardson AJ, Puri BK.
A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.
Prog Neuropsychopharm Biol Psychiat 26(2):233-9; 2002 |
2002 |
Hämta här |
5. Richardson AJ, Montgomery P.
The Oxford-Durham Study: A Randomized, Controlled Trial of Dietary Supplementation with Fatty Acids in Children with Developmental Coordination Disorder.
Pediatrics 115: 1360-1366; 2005 |
2005 |
Hämta här |
6. Birch EE, Hoffman DR, Castaneda YS, et al.
A randomized controlled trial of long-chain polyunsturated fatty acid supplementation of formula in term infants after weaning at 6 weeks of age.
Am J Clin Nutrition 75:570-80; 2002 |
2002 |
|
7. Peet M.
Essential fatty acids: theoretical aspects and treatment implications for schizophrenia and depression.
Advances in Psychiatric Treatment 8:223-9; 2002 |
2002 |
Hämta här |
8. Bell G.
Phospholipid Spectrum Disorders in Autism. |
2002 |
Hämta här |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
